Treatment options for patients with recurrent or metastatic squamous cell carcinoma of the head and neck, who progress after platinum-based chemotherapy. [electronic resource]
Producer: 20120619Description: 211-7 p. digitalISSN:- 1531-703X
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Squamous Cell -- drug therapy
- Cetuximab
- Clinical Trials as Topic
- Disease-Free Survival
- ErbB Receptors -- drug effects
- Female
- Head and Neck Neoplasms -- drug therapy
- Humans
- Male
- Neoplasm Recurrence, Local -- drug therapy
- Palliative Care -- methods
- Panitumumab
- Platinum Compounds -- administration & dosage
- Prognosis
- Survival Analysis
- Treatment Failure
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.